Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine Granules for Prevention of Recurrence of Diverticulitis
NCT01038739Phase 3Terminated
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jan 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in diverticulitis, sponsored by Dr. Falk Pharma GmbH. Started Jan 2010; status: terminated.
02
Drugs
Salcrozine
03
Conditions
diverticulitis
Beyond the preview
Go deeper on NCT01038739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038739.